The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Oral Session

Oral Session 1-8D Malignant Lymphoma: Clinical studies

Fri. Oct 12, 2018 4:20 PM - 5:20 PM No.8 (Osaka International Convention Center, 10F 1002)

Chair: Koji Izutsu (National Cancer Center Hospital, Japan)

[OS1-8D-2] Phase 1 study of tazemetostat in Japanese patients with relapsed or refractory B-cell NHL

Yukari Shirasugi1, Wataru Munakata2, Kiyoshi Ando1, Shinichi Makita2, Makoto Onizuka1, Dai Maruyama2, Rikio Suzuki1, Koji Izutsu2, Hidetsugu Kawai1, Tadashi Nakanishi3, Sari Shiba4, Kensei Tobinai2 (1.Haematology and Oncology, Tokai University School of Medicine, Isehara, Japan, 2.Department of Hematology, National Cancer Hospital, Tokyo, Japan, 3.Department of Clinical Development, Eisai Co., Ltd., Tokyo, Japan, 4.Department of Clinical Pharmacology, Eisai Co., Ltd., Tokyo, Japan)

Abstract password authentication.
Password is written on a program and abstract book.

Password